Abstract

A devastating complication of Plasmodium falciparum infection is cerebral malaria, in which vascular leakage and cerebral swelling lead to coma and often death. P. falciparum produces a protein called histidine-rich protein II (HRPII) that accumulates to high levels in the bloodstream of patients and serves as a diagnostic and prognostic marker for falciparum malaria. Using a human cerebral microvascular endothelial barrier model, we previously found that HRPII activates the endothelial cell inflammasome, resulting in decreased integrity of tight junctions and increased endothelial barrier permeability. Here, we report that intravenous administration of HRPII induced blood-brain barrier leakage in uninfected mice. Furthermore, HRPII infusion in P. berghei-infected mice increased early mortality from experimental cerebral malaria. These data support the hypothesis that HRPII is a virulence factor that contributes to cerebral malaria by compromising the integrity of the blood-brain barrier.

Highlights

  • Malaria is a disease that afflicts several hundred million people each year

  • Infection of mice with the rodent malaria parasite strain P. berghei ANKA serves as a small animal model for cerebral malaria

  • We showed that histidine-rich protein II (HRPII) can disrupt a human cerebral endothelial cell barrier in vitro [11]

Read more

Summary

Introduction

Malaria is a disease that afflicts several hundred million people each year. Most of the estimated 600,000 deaths [1] are due to the species Plasmodium falciparum, which can cause complications such as severe anemia, respiratory distress and cerebral malaria (CM). CM manifests with a progression of symptoms from decreased consciousness to coma and death. Cerebral edema due to blood-brain barrier (BBB) compromise results in brain herniation and death [2]. Infection of mice with the rodent malaria parasite strain P. berghei ANKA serves as a small animal model for cerebral malaria. The pathology present in experimental cerebral malaria

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call